エーザイ（4523）　PHASE III TRIAL OF ANTICANCER AGENT LENVIMA AS FIRST-LINE TREATMENT FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA MEETS PRIMARY ENDPOINT 2017/01/25
/-
読み込み中…